5 stories mentioning HKG:2661Updated 51d ago
Every FINWIRES story that references HKG:2661, newest first.
QingSong Health (HKG:2661) is planning to buy back up to HK$100 million of shares from the open market, according to a Monday Hong Kong bourse filing.Shares of the telehealth company were down nearly 6% in Tuesday afternoon trading.The shares will be repurchased from time to time until the firm's annual general meeting.
QingSong Health (HKG:2661) said it entered a strategic cooperation memorandum with Nasdaq-listed Basel Medical Group, according to a Wednesday filing with the Hong Kong bourse.The three year agreement will see QingSong Health combine its healthcare AI infrastructure with Basel Medical's clinical settings and market access in Southeast Asia to jointly explore new market opportunities.
QingSong Health (HKG:2661) unit Beijing QingSong Health Network Technology entered into three health management service cooperation agreements with Yingda Taihe Life Insurance,The scope of the contract includes medical treatment services and chronic disease management, health promotion and disease prevention, and rehabilitation and nursing.Under the cooperation, telehealth firm QingSong Health will provide various customers of Yingda Taihe Life Insurance with health management and related ancillary services.
QingSong Health (HKG:2661) named You Mucong as its CFO, effective Monday, according to a same-day Hong Kong bourse filing.Shares of the telehealth company were down 2% in Tuesday afternoon trading.You has served as the founding partner of J&R Capital since January 2021 and established the integrated platform Select Health.
QingSong Health (HKG:2661) embedded its artificial intelligence-based medical agent QSevidence within its QSmedical platform, according to a Hong Kong bourse filing on Sunday.QSevidence is an evidence-based medical agent designed to help physicians make medical decisions.The embedding comes amid a 46% year on year rise in the number of medical professional users on the company's QSmedical platform in the first quarter of the year. The firm said 69,615 professionals were using its platform as of March 31, compared with 47,554 in the same period last year.
